Drupal.behaviors.print = function(context) {window.print();window.close();}>
Qiagen Teams with Max Planck on TB MDx Test
January 09, 2012
Qiagen Teams with Max Planck on TB MDx Test
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Qiagen Expands Companion Dx Portfolio with Three Licensing Deals; Exceeds 2012 QiaSymphony Placement Target
January 7, 2013 / GenomeWeb Daily News
Qiagen, Max Planck Developing qPCR-Based Test for Active TB Risk in Latently Infected Patients
January 12, 2012 / PCR Insider
Revising Molecular Dx Roadmap, Qiagen Will Migrate PCR Tests Across Automated Platforms
May 12, 2011 / PCR Insider
Alere Garners Up to $42.2M in Grants and Loans from Gates Foundation for POC MDx Platforms
March 1, 2013 / GenomeWeb Daily News
Qiagen Q4, 2012 Growth Driven Significantly by QiaSymphony Sales in MDx, Applied Markets
January 31, 2013 / PCR Insider